CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 138 filers reported holding CLOVIS ONCOLOGY INC in Q1 2014. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $551,000 | +4.6% | 6,000 | 0.0% | 0.27% | +15.1% |
Q2 2015 | $527,000 | +18.4% | 6,000 | 0.0% | 0.24% | +17.8% |
Q1 2015 | $445,000 | +32.4% | 6,000 | 0.0% | 0.20% | +36.5% |
Q4 2014 | $336,000 | +23.5% | 6,000 | 0.0% | 0.15% | +21.3% |
Q3 2014 | $272,000 | +9.7% | 6,000 | 0.0% | 0.12% | +8.9% |
Q2 2014 | $248,000 | -40.2% | 6,000 | 0.0% | 0.11% | -43.7% |
Q1 2014 | $415,000 | +15.0% | 6,000 | 0.0% | 0.20% | +14.4% |
Q4 2013 | $361,000 | -0.8% | 6,000 | 0.0% | 0.17% | -9.4% |
Q3 2013 | $364,000 | -22.2% | 6,000 | -14.3% | 0.19% | -25.6% |
Q2 2013 | $468,000 | – | 7,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |